SARS-CoV-2 seroprevalence among patients with severe mental illness: A cross-sectional study

Patients with severe mental illness (SMI) i.e. schizophrenia, schizoaffective disorder, and bipolar disorder are at increased risk of severe outcomes if infected with coronavirus disease 2019 (COVID-19). Whether patients with SMI are at increased risk of COVID-19 is, however, sparsely investigated....

Descripción completa

Detalles Bibliográficos
Autores principales: Sass, Marie Reeberg, Juul, Tobias Søgaard, Skov, Robert, Iversen, Kasper, Harritshøj, Lene Holm, Sørensen, Erik, Ostrowski, Sisse Rye, Andersen, Ove, Ekstrøm, Claus Thorn, Ullum, Henrik, Nielsen, Jimmi, Hageman, Ida, Fink-Jensen, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887729/
https://www.ncbi.nlm.nih.gov/pubmed/35231037
http://dx.doi.org/10.1371/journal.pone.0264325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887729/
https://www.ncbi.nlm.nih.gov/pubmed/35231037
http://dx.doi.org/10.1371/journal.pone.0264325

Ejemplares similares